ALL IN, YET AGAIN Tue Sep 25, 2012 10:29am 15 I added to my DDD, JIVE and ESRX positions. In addition, I started a new position in ULTA, for the $100 roll. Cash is back down to 10%. Tweet 15 Responses to “ALL IN, YET AGAIN” clegger_2000 September 25, 2012 at 10:34 am Engineers indeud… Let me know if you need any assistance with the OSC program. sspiff September 25, 2012 at 11:19 am I have some friends working on stabilization of large space structures and targeting systems. Just kidding of course. clegger_2000 September 25, 2012 at 12:17 pm Back in the day I worked on targeting systems for the Cobra and Apache attach helicopters. Booyah I am a real life engineer clegger_2000 September 25, 2012 at 12:18 pm attack… oops The Zombie September 25, 2012 at 10:37 am The Fly is God. ruggyup September 25, 2012 at 10:39 am Nobody but nobody will know the secrets of my portfolio and transactions. See: http://www.americanscientist.org/issues/pub/2012/5/alice-and-bob-in-cipherspace Now, fully homomorphic encryption. Even sounds cool. donker September 25, 2012 at 10:48 am FLY take a look at ING….very solid consolidation donker September 25, 2012 at 10:48 am lets not forget RDN republicat September 25, 2012 at 11:06 am Onboard with ESRX: Given the fundies, growth numbers, announced expansion, PPT stats for ESRX-> If this thing can’t move higher over the next 30 days – nothing can. Juice September 25, 2012 at 11:13 am SEÑOR Fly has el grande cajones zzzdoc September 25, 2012 at 12:47 pm yes, his drawers are big! JTU September 25, 2012 at 12:17 pm This market is tiring the fuck out of me! I was up 9% for the first two weeks of August only to see half of it evaporated since last week. I find myself in the position of owning too many losers and am getting close to going all cash if things don’t improve for me in a hurry! charlie September 25, 2012 at 12:20 pm A bold move. Freebie September 25, 2012 at 12:28 pm That GMO movie is fascinating, I buy organic already, but is it really based on science? Check out this point for point rebuttal: http://academicsreview.org/reviewed-content/genetic-roulette/ JTU September 25, 2012 at 12:32 pm Looks like CAT’s outlook has shaken the market, along with expected lower third quarter earnings and the fiscal cliff on the horizon. Comments are closed.